Neuroimmunology News


Sep 18, 2017
Study uncovers markers for severe form of multiple sclerosis
Scientists have uncovered two closely related cytokines that may explain why some people develop progressive multiple sclerosis, perhaps pointing the way toward developing a novel treatment to prevent progressive forms of the disease.
Sep 13, 2017
Vitamin D levels in blood may help predict risk of multiple sclerosis
Study suggests that correcting vitamin D deficiency in young and middle-age women may reduce their future risk of multiple sclerosis.
Aug 08, 2017
One step closer in explaining multiple sclerosis relapse during upper respiratory infection
Researchers shed light on what may be happening in the brains of MS patients during upper respiratory infections
Jul 27, 2017
Immune system may mount an attack in Parkinson disease
Study suggests that T cells, which help the body's immune system recognize friend from foe, may play an important role in Parkinson disease.
Jul 10, 2017
Hidden herpes virus may play key role in multiple sclerosis and other brain disorders
The ubiquitous human herpesvirus 6 (HHV-6) may play a critical role in impeding the brain's ability to repair itself in diseases like multiple sclerosis.
Jun 30, 2017
Patients with multiple sclerosis may benefit from over-the-counter therapy
A pilot study suggests over-the-counter antioxidant lipoic acid holds promise in improving multiple sclerosis (MS) patients' lives.The study revealed a 68% improvement over placebo in slowing the rate of whole brain atrophy in patients with secondary progressive MS. The research is published in the journal Neuroimmunology & Neuroinflammation.
Jun 14, 2017
A surprising new link between inflammation and mental illness
New research from Boston Children's Hospital has shed light on the cause of neuropsychiatric symptoms in systemic lupus erythematosus and points to a potential new drug for protecting the brain from the neuropsychiatric effects of lupus and other CNS diseases. The team has published its surprising findings in Nature.
Feb 22, 2017
tDCS combined with computer games at home reduces cognitive symptoms of multiple sclerosis
Patients with multiple sclerosis had better problem solving ability and response time after training with transcranial direct current stimulation (tDCS), according to a new study published February 22, 2017 in Neuromodulation: Technology at the Neural Interface.
Jan 23, 2017
Serum micoRNAs may serve as biomarkers for multiple sclerosis
In a new study published today in JAMA Neurology, researchers have found that serum microRNAs are linked to MRI findings in the brain and spinal cord in patients with multiple sclerosis (MS). These findings suggest that microRNAs could serve as promising biomarkers for monitoring the progression of MS.
Jan 18, 2017
Researchers discover severe side effects of approved multiple sclerosis medication
The multiple sclerosis therapy alemtuzumab can trigger severe, unpredictable side effects, finds by a team led by German researchers published in the journal Lancet Neurology. The team also describes a treatment that successfully curbed the harmful side effects.
Next ▶